Earnings wrap: Emdeon, Symbion

Payment services provider says adjusted EBITDA up slightly, spike in cost of supplies bites surgery center chain
Nov 12, 2012 1:36 PM

AmSurg to issue $250M in debt

Prepping for more M&A, surgery center chain will pay down revolver
Nov 7, 2012 11:08 AM

Earnings wrap: AmSurg, Noranda

Surgery center chain eyeing more M&A; low aluminum prices hurt Franklin manufacturer's numbers
Oct 24, 2012 12:25 PM

Local health care companies seeking partners in wake of ‘Obamacare’

Growing M&A wave driven by multiple factors
Oct 7, 2012 11:00 PM

AmSurg buying in Chicago

Burton Hills-based AmSurg has signed a deal to acquire a majority stake in a surgery center on the north side of Chicago for almost $8 million. Illinois regulators still need to approve the acquisition, news of which is coming to light a month after AmSurg paid $6.2 million for a majority stake in an undisclosed center. (Search the company's recent 10-Q for "July 2012.")

The doctors have agreed not to work for a competing surgical center for five years after the transaction closes, or two years after they sell their remaining ownership interests, according to the letter of intent.

Aug 31, 2012 7:04 AM

Top AmSurg operations exec sets retirement date

Payne joined surgery center chain in '96
Aug 17, 2012 7:06 AM

More option gains for AmSurg CFO

Claire Gulmi, CFO of surgery center chain AmSurg, has exercised more than 56,000 options that were set to expire in early 2014. Her gain on the transactions tops $340,000. Gulmi two months ago made a similar move that generated more than $800,000 in profits.

Aug 14, 2012 9:48 AM

Real estate notes: AmSurg inks airport-area lease

Also: Big Lots in Gallatin
Aug 7, 2012 2:24 PM

Co-founder of Symbion majority owner leaves board

As of Wednesday, the board of surgery center chain Symbion has a new member. Dan Kilpatrick, a vice president of Symbion majority owner Crestview Partners and pictured here, has replaced Crestview co-founder Tom Murphy. In a filing with regulators, Symbion said Murphy's resignation was not due to any disagreements with the company.

Aug 3, 2012 9:38 AM

Analyst action: Healthways, AmSurg

A number of analysts tracking Healthways have reacted positively to the company's Q2 profits. At Stifel Nicolaus, Thomas Carroll has hiked his price target for the Franklin-based company, which he rates a 'buy,' to $13 from $10. Michael Petusky at Noble Financial has upgraded Healthways (Ticker: HWAY) to 'buy' from 'hold' and given it a $12 target.

Not so enthused is Art Henderson at Jefferies, who has downgraded shares of AmSurg to 'hold' after the surgery center chain's Q2 numbers. Nashville-based Henderson says he has "serious concerns" about AmSurg's valuation given various macroeconomic uncertainties. His new $27 target is about 10 percent below where AmSurg (Ticker: AMSG) is changing hands this morning.

Jul 26, 2012 9:45 AM